Archive for December 22, 2020

Climate change and COVID-19 vaccines are among the themes set to shape research. Climate comeback 2021 looks set to be a pivotal year for the fight against climate change. US president-elect Joe Biden has made clear that he will move to restore the country’s leadership in that regard, including by rejoining the Paris climate agreement…

The latest on the innovations that will let us go back to normal. This has been a devastating year. More than 1.6 million people have died in the COVID-19 pandemic, with more than 75 million cases and tens of trillions of dollars in economic damages. Millions of people are out of work and struggling to…

Vaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer and BioNTech, one from Moderna — have received emergency use authorizations by the Food and Drug Administration. Both vaccines have been deemed safe, but they can cause some short-term side effects. Vaccines are designed to invoke an immune response that…

Dive Brief: Moderna has fully enrolled the late-stage study testing its experimental coronavirus vaccine, recruiting 30,000 volunteers from across America in just three months as the company presses forward in an extraordinary push to quickly prove its shot can prevent COVID-19.  More than 25,000 of those study participants have now received their second and final…

As a young girl, Amina Ahmed watched her grandmother, Hauwa’u Musa, guide women through labours that lasted for hours. And, just like her grandmother, she spent years perfecting her own midwifery skills. She did this in homes across Kano, the largest city in northern Nigeria.  “She taught me everything I know,” says Ahmed over the phone from her…

While there is no specific vaccine on the table yet, the committee is hearing from federal agencies and vaccine makers about their efforts to prove a shot is both safe and effective. An expert panel advising the Food and Drug Administration on coronavirus vaccines wants more details on who is volunteering for trials and how…

U.S. biotechs rounded up $19.5 billion in venture capital through Sept. 30, topping the $17.4 billion they raised for all of 2019. Investors are pumping billions of dollars into biotechnology startups and paying skyrocketing prices for their stakes in the most-promising new drug companies. U.S. biotechs rounded up $19.5 billion in venture capital through Sept.…

Alarge new study finds that mental health care for many children in the U.S. falls far short, particularly when it comes to the follow-up treatment they receive. The study, published Monday in Proceedings of the National Academy of Sciences, examined insurance claims from children between the ages of 10 and 17 covered by Blue Cross Blue…

Think back through the pandemic. Think about the moments that stand out as beacons in the haze — signposts of how it would change all of our lives. Not all of these moments were clear at the time. China’s decision to shut down cities of millions of people in January was staggering, but to most…